Cipla gets CDSCO panel nod for BE study of idiopathic pulmonary fibrosis drug Pirfenidone Medical Dialogues Team7 Sept 2021 2:59 PM ISTNew Delhi: Pharmaceutical major, Cipla has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
NPPA panel rejects Cipla application for special pricing of Ciphaler Inhaler Device Medical Dialogues Team26 Aug 2021 5:27 PM ISTNew Delhi: Rejecting pharmaceutical major Cipla's application, the National Pharmaceutical Pricing Authority (NPPA) Committee has denied to allow a...
Cipla, Kemwell Biopharma collaborate to develop, commercialize biosimilars Ruchika Sharma26 Aug 2021 10:00 AM ISTMumbai: Cipla Limited, a global pharmaceutical company and Kemwell Biopharma Private Limited, a biopharmaceutical Contract Development and...
Conduct phase 3 trial of Nafamostat Mesilatefor for marketing approval: CDSCO panel tells Cipla Medical Dialogues Team15 Aug 2021 11:30 AM ISTNew Delhi: Rejecting drug maker Cipla's proposal to market and manufacture Nafamostat Mesilate for injection at 50 mg/vial and 100mg/vial, the Subject...
44 drug samples including Cipla Remdesivir fail to qualify CDSCO test, 1 declared misbranded Medical Dialogues Team14 Aug 2021 3:11 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 44...
Cipla bags USFDA nod for generic version of Durezol Ruchika Sharma12 Aug 2021 2:15 PM ISTMumbai: Drug major, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Cipla recalls Solifenacin Succinate tablets in US over manufacturing issues Ruchika Sharma26 July 2021 1:30 PM ISTNew Delhi: Drug major Cipla is recalling 7,228 bottles of Solifenacin Succinate tablets, a medicine used to treat overactive bladder, in the US market...
Covid-19: JnJ, Pfizer yet to apply for license of vaccines in India Ruchika Sharma18 July 2021 9:15 AM ISTNew Delhi: The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation...
NPPA fixes ceiling price of Amphotericin B Emulsion Injection to treat Black Fungus Medical Dialogues Team11 July 2021 11:30 AM ISTNew Delhi: Through a recent Office Memorandum, the National Pharmaceutical Pricing Authority (NPPA) has confirmed the ceiling price of antifungal drug...
Cipla arm's oral liquid dosage, nasal product unit acquired by Rubicon Research Ruchika Sharma11 July 2021 11:00 AM ISTNew Delhi: Specialty pharma firm Rubicon Research on Friday said it has acquired Meditab Specialities'' oral liquid dosage and nasal product...
NPPA fixes retail price of 11 formulations, Details Medical Dialogues Team10 July 2021 1:58 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
One Time Rise: NPPA approves 50 percent price hike for Carbamazepine, Ranitidine, Ibuprofen Medical Dialogues Team3 July 2021 10:55 AM ISTNew Delhi: Through a recent gazette notification, the National Pharmaceutical Pricing Authority (NPPA) has allowed a one-time hike of 50 per cent in...
